Radiopharm Theranostics Ltd
SEC CIK 1949257 · RADX · last insider filing 2026-05-06
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Hopper Paul | Director | filed 2026 - 2026 |
| Donnelly Noel | Director | filed 2026 - 2026 |
| Turner Ian Lawrence | Director | filed 2026 - 2026 |
| Canevari Riccardo | Director · Managing Director and CEO | filed 2026 - 2026 |
| Larkin Hester Denise | Director | filed 2026 - 2026 |
| Goodwin Bruce Michael | Director | filed 2026 - 2026 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Voliotis Dimitris | Chief Medical Officer | filed 2026 - 2026 |
| Laurita Aaron James | Chief Financial Officer | filed 2026 - 2026 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.